Last update 01 Nov 2024

Indivior Europe Ltd.

Subsidiary Company|
Ireland

Overview

Tags

Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
OOR x κ opioid receptor x μ opioid receptor1

Related

1
Drugs associated with Indivior Europe Ltd.
Buprenorphine Hydrochloride/Naloxone Hydrochloride
Target
OOR x κ opioid receptor x μ opioid receptor
Mechanism
OOR agonists [+2]
Active Org.
Nanchang Lijian Pharmaceutical Co. Ltd.Nanchang Lijian Pharmaceutical Co. Ltd. [+6]
Originator Org.
Indivior PLC
Active Indication
Opioid-Related Disorders [+3]
Inactive Indication
opioid dependence methadone [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date08 Oct 2002
1
Clinical Trials associated with Indivior Europe Ltd.
DRKS00026176 / CompletedNot Applicable
Patient-relevant outcomes in the routine treatment of patients with Opioid Use Disorder (OUD) in Germany using Suboxone® Sublingual Film - PROFIL
100 Clinical Results associated with Indivior Europe Ltd.
Login to view more data
0 Patents (Medical) associated with Indivior Europe Ltd.
Login to view more data
100 Deals associated with Indivior Europe Ltd.
Login to view more data
100 Translational Medicine associated with Indivior Europe Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Buprenorphine Hydrochloride/Naloxone Hydrochloride
 ( OOR x κ opioid receptor x μ opioid receptor )		Opioid-Related Disorders
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free